(Q70866680)
Statements
Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril (English)
Y Furukawa
A Matsumori
T Hirozane
scientific article published on 01 January 1996